Published in Cancer Weekly, January 24th, 2012
"However, to date there are still no effective targeted therapies for this genetically defined subset of patients. Here we report the results of a small...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.